Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Ho Jun Seol
Affiliation
Samsung Medical Center, Sungkyunkwan University School of Medicine
ORCID
Career Start Year
2001
Papers
165
H Index
30
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36283649
Impact of Postural Changes on Sinonasal Pressure After Endoscopic Endonasal Surgery.
World Neurosurg
2023
36283649
Impact of Postural Changes on Sinonasal Pressure After Endoscopic Endonasal Surgery.
World Neurosurg
2023
37938445
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
J Neurooncol
2023
37861921
Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
J Neurooncol
2023
36719016
Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma.
Yonsei Med J
2023
36642947
Effect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience.
J Korean Neurosurg Soc
2023
36977865
A single-center prospective study regarding time to return to activities of daily living after craniotomy for brain tumors.
Acta Neurochir (Wien)
2023
36915208
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.
Genome Med
2023
37861921
Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
J Neurooncol
2023
37938445
Correction to: Impact of boost sequence in concurrent chemo-radiotherapy on newly diagnosed IDH-wildtype glioblastoma multiforme.
J Neurooncol
2023
36977865
A single-center prospective study regarding time to return to activities of daily living after craniotomy for brain tumors.
Acta Neurochir (Wien)
2023
36719016
Clinical Outcomes of Moderately Hypofractionated Concurrent Chemoradiotherapy for Newly Diagnosed Glioblastoma.
Yonsei Med J
2023
36915208
Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma.
Genome Med
2023
36642947
Effect of Bevacizumab Treatment in Cerebral Radiation Necrosis : Investigation of Response Predictors in a Single-Center Experience.
J Korean Neurosurg Soc
2023
34767991
Graded Reconstruction Strategy Using a Multilayer Technique Without Lumbar Drainage After Endoscopic Endonasal Surgery.
World Neurosurg
2022
35739135
Clinical outcomes of patients with multiple courses of radiosurgery for brain metastases from non-small cell lung cancer.
Sci Rep
2022
35489600
Factors Associated with Acute Obstructive Hydrocephalus After Retrosigmoid Approach for Extra-Axial Cerebellopontine Angle Tumors.
World Neurosurg
2022
35488013
Combined endoscopic endonasal and transorbital multiportal approach for complex skull base lesions involving multiple compartments.
Acta Neurochir (Wien)
2022
35600408
Clinical Impact of Hydroxyapatite on the Outcome of Skull Base Reconstruction for Intraoperative High-Flow CSF Leak: A Propensity Score Matching Analysis.
Front Oncol
2022
34728396
Treatment Strategy for Giant Solid Hemangioblastomas in the Posterior Fossa: AÂ Retrospective Review of 13 Consecutive Cases.
World Neurosurg
2022
35194082
Histopathology and surgical outcome of symptomatic treatment-related changes after gamma knife radiosurgery in patients with brain metastases.
Sci Rep
2022
34958988
Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.
World Neurosurg
2022
34767991
Graded Reconstruction Strategy Using a Multilayer Technique Without Lumbar Drainage After Endoscopic Endonasal Surgery.
World Neurosurg
2022
35094201
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma.
J Neurooncol
2022
35739135
Clinical outcomes of patients with multiple courses of radiosurgery for brain metastases from non-small cell lung cancer.
Sci Rep
2022
35600408
Clinical Impact of Hydroxyapatite on the Outcome of Skull Base Reconstruction for Intraoperative High-Flow CSF Leak: A Propensity Score Matching Analysis.
Front Oncol
2022
35489600
Factors Associated with Acute Obstructive Hydrocephalus After Retrosigmoid Approach for Extra-Axial Cerebellopontine Angle Tumors.
World Neurosurg
2022
35488013
Combined endoscopic endonasal and transorbital multiportal approach for complex skull base lesions involving multiple compartments.
Acta Neurochir (Wien)
2022
35094201
Bevacizumab plus irinotecan with or without gamma knife radiosurgery after failure of concurrent chemo-radiotherapy for high-grade glioma.
J Neurooncol
2022
34958988
Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.
World Neurosurg
2022
35194082
Histopathology and surgical outcome of symptomatic treatment-related changes after gamma knife radiosurgery in patients with brain metastases.
Sci Rep
2022
34728396
Treatment Strategy for Giant Solid Hemangioblastomas in the Posterior Fossa: AÂ Retrospective Review of 13 Consecutive Cases.
World Neurosurg
2022
32929542
Stereotactic radiosurgery for orbital cavernous venous malformation: a single center's experience for 15 years.
Acta Neurochir (Wien)
2021
31758338
Comparison between retrosigmoid and translabyrinthine approaches for large vestibular schwannoma: focus on cerebellar injury and morbidities.
Neurosurg Rev
2021
33904259
Optimal Volume of the Residual Tumor to Predict Long-term Tumor Control Using Stereotactic Radiosurgery after Facial Nerve-preserving Surgery for Vestibular Schwannomas.
J Korean Med Sci
2021
34002303
Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction.
J Neurooncol
2021
33771748
Safety and Efficacy of Endoscopic Dorsum Sellar Resection for Access to Retroinfundibular or Upper Clival Tumors (Korean Society of Endoscopic Neurosurgery-008).
World Neurosurg
2021
32929542
Stereotactic radiosurgery for orbital cavernous venous malformation: a single center's experience for 15 years.
Acta Neurochir (Wien)
2021
33267531
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
J Korean Neurosurg Soc
2021
34416715
Endoscopic endonasal and transorbital approaches to petrous apex lesions.
J Neurosurg
2021
33771748
Safety and Efficacy of Endoscopic Dorsum Sellar Resection for Access to Retroinfundibular or Upper Clival Tumors (Korean Society of Endoscopic Neurosurgery-008).
World Neurosurg
2021
33904259
Optimal Volume of the Residual Tumor to Predict Long-term Tumor Control Using Stereotactic Radiosurgery after Facial Nerve-preserving Surgery for Vestibular Schwannomas.
J Korean Med Sci
2021
34416715
Endoscopic endonasal and transorbital approaches to petrous apex lesions.
J Neurosurg
2021
34002303
Early hormonal recovery following endoscopic transsphenoidal surgery for silent non-functioning pituitary adenomas with hormone dysfunction.
J Neurooncol
2021
31758338
Comparison between retrosigmoid and translabyrinthine approaches for large vestibular schwannoma: focus on cerebellar injury and morbidities.
Neurosurg Rev
2021
33267531
Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery.
J Korean Neurosurg Soc
2021
31096737
Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
Cancer Res Treat
2020
32371318
Two-staged gamma knife radiosurgery for treatment of numerous (>10) brain metastases.
Clin Neurol Neurosurg
2020
32312626
Pattern of disease progression following stereotactic radiosurgery in malignant glioma patients.
J Clin Neurosci
2020
32120790
Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening.
Cancers (Basel)
2020
1 - 50 of 330
Column Actions
Search
Recommended Authors
Felix Behling
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year
2015
Number of shared co-authors
0
Johannes Kerschbaumer
Medical University of Innsbruck
Career Start Year
2012
Number of shared co-authors
5
Noriyuki Kijima
Osaka University Graduate School of Medicine
Career Start Year
2011
Number of shared co-authors
3
Farshad Nassiri
Toronto Western Hospital, University Health Network, University of Toronto
Career Start Year
2010
Number of shared co-authors
2
Christian F Freyschlag
Medical University of Innsbruck
Career Start Year
2010
Number of shared co-authors
5
Arman Jahangiri
Hamadan University of Medical Sciences
Career Start Year
2010
Number of shared co-authors
3
Jenny Kan-Suen Pu
Queen Mary Hospital
Career Start Year
2009
Number of shared co-authors
1
Rohan Ramakrishna
Weill Cornell Medical College, New York Presbyterian Hospital
Career Start Year
2009
Number of shared co-authors
0
Yoshua Esquenazi
McGovern Medical School at UT Health Houston
Career Start Year
2007
Number of shared co-authors
0
Stephen T Magill
Feinberg School of Medicine, Northwestern University
Career Start Year
2006
Number of shared co-authors
2
Sherise D Ferguson
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
3
Gelareh Zadeh
University of Toronto
Career Start Year
2003
Number of shared co-authors
12
Muh-Lii Liang
MacKay Memorial Hospital
Career Start Year
2003
Number of shared co-authors
2
Marco Skardelly
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year
2002
Number of shared co-authors
1
Ichiyo Shibahara
Kitasato University School of Medicine
Career Start Year
2002
Number of shared co-authors
1
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year
2001
Number of shared co-authors
0
Naoki Shinojima
Kumamoto University Hospital
Career Start Year
2000
Number of shared co-authors
2
Franz Marhold
Karl Landsteiner University of Health Sciences
Career Start Year
1998
Number of shared co-authors
5
John A Boockvar
Lenox Hill Hospital
Career Start Year
1997
Number of shared co-authors
0
Manish K Aghi
University of California san francisco
Career Start Year
1997
Number of shared co-authors
3
Ganesh Rao
The University of Texas M.D. Anderson Cancer Center
Career Start Year
1994
Number of shared co-authors
12
Clark C Chen
University of Minnesota
Career Start Year
1994
Number of shared co-authors
2
Torstein R Meling
The National Hospital of Denmark, Rigshospitalet
Career Start Year
1993
Number of shared co-authors
0
Michael W McDermott
University of California san francisco
Career Start Year
1989
Number of shared co-authors
2
Toshihiro Kumabe
Kitasato University School of Medicine
Career Start Year
1988
Number of shared co-authors
4
Ryo Nishikawa
Saitama Medical University International Medical Center
Career Start Year
1986
Number of shared co-authors
1
Michael A Vogelbaum
Moffit Cancer Center
Career Start Year
1986
Number of shared co-authors
4
Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Career Start Year
1984
Number of shared co-authors
4
Ian E McCutcheon
The University of Texas M.D. Anderson Cancer Center
Career Start Year
1981
Number of shared co-authors
6
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Career Start Year
1979
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers
120
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers
114
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
110
Jung Won Choi
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
47
Sang Duk Hong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
19
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers
18
Sung Tae Kim
Busan Paik Hospital, Inje University
Co-authored papers
17
Chul-Kee Park
College of Medicine, Seoul National University
Co-authored papers
15
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers
12
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers
11
Seung Won Choi
Samsung Medical Center, Sungkyunkwan University
Co-authored papers
10
Jason K Sa
Korea University, College of Medicine
Co-authored papers
10
Yeon-Lim Suh
Samsung Medical Center, Sungkyunkwan University College of Medicine
Co-authored papers
9
Hyemi Shin
Research Institute for Future Medicine, Samsung Medical Center
Co-authored papers
9
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers
9
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Co-authored papers
8
Byung Sup Kim
Kosin University Gospel Hospital, Kosin University College of Medicine
Co-authored papers
8
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
8
In-Hee Lee
Co-authored papers
7
Donggeon Kim
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
7
In-Hee Lee
Children's Hospital Boston
Co-authored papers
7
Seung-Ki Kim
Seoul National University Children's Hospital
Co-authored papers
7
James T Rutka
Hospital for Sick Children
Co-authored papers
6
Raul Rabadan
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers
6
Hyun Ju Kang
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers
6
Harim Koo
Korea University College of Medicine
Co-authored papers
6
Jinkuk Kim
Korea Advanced Institute of Science and Technology (KAIST)
Co-authored papers
5
Jin-Ku Lee
Seoul National University, College of Medicine
Co-authored papers
5
Zhaoqi Liu
University of Chinese Academy of Sciences
Co-authored papers
4
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers
4
1 - 30